Published in AIDS Res Hum Retroviruses on December 01, 1994
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A (2000) 11.51
Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol (1998) 2.46
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol (2003) 2.36
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc Natl Acad Sci U S A (2001) 2.32
Immunity to retroviral infection: the Friend virus model. Proc Natl Acad Sci U S A (1997) 2.28
Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J Virol (1997) 2.16
Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol (2002) 1.98
Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol (1995) 1.50
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol (2000) 1.38
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. J Virol (1997) 1.30
Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J Virol (1995) 1.09
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest (1996) 1.02
Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections. J Virol (1998) 0.98
Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. J Clin Invest (1997) 0.91
The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection. Curr Infect Dis Rep (2002) 0.87
Prolonged dominance of clonally restricted CD4(+) T cells in macaques infected with simian immunodeficiency viruses. J Virol (2000) 0.79
MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy. J Clin Invest (2001) 0.76
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31
In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med (1995) 6.26
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A (1992) 5.88
The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med (1996) 5.56
Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med (1975) 5.41
Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92
Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest (2001) 4.37
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res Hum Retroviruses (1993) 3.80
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay. J Clin Microbiol (1990) 3.80
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2003) 3.45
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med (2000) 3.44
Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J Bacteriol (1990) 3.36
Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med (1969) 3.19
Statistical shape analysis of neuroanatomical structures based on medial models. Med Image Anal (2003) 3.17
Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc Natl Acad Sci U S A (1994) 2.88
Bulgeless dwarf galaxies and dark matter cores from supernova-driven outflows. Nature (2010) 2.71
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med (1996) 2.67
Safety of home delivery compared with hospital delivery in The Eastern Region Health Authority in Ireland in the years 1999-2002. Ir Med J (2003) 2.66
Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood (2000) 2.65
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol (1992) 2.58
HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol (1996) 2.58
Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med (1999) 2.54
Detecting antibodies to human immunodeficiency virus in dried blood on filter papers. J Infect Dis (1987) 2.47
Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology (2004) 2.40
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry (2001) 2.35
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain. Proc Natl Acad Sci U S A (1990) 2.29
Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion. Am J Epidemiol (2001) 2.22
Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains. J Biol Chem (1985) 2.18
Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA (1998) 2.16
The silent treatment: siRNAs as small molecule drugs. Gene Ther (2006) 2.12
The international epidemiology of AIDS. Sci Am (1988) 2.08
Rapid formation of supermassive black hole binaries in galaxy mergers with gas. Science (2007) 2.06
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay. Lancet (1991) 2.06
Clinico-pathological findings in non-immune hydrops fetalis. Ir Med J (1991) 2.05
Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis (1979) 2.04
Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci U S A (1976) 2.00
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Ann Intern Med (1993) 1.99
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci U S A (1984) 1.99
Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol (1994) 1.97
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci U S A (1984) 1.94
The multicenter AIDS Cohort Study, 1983 to …. Public Health (2011) 1.93
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia (2009) 1.92
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS (2001) 1.84
Mutations in a gene encoding a new oxygen-regulated photoreceptor protein cause dominant retinitis pigmentosa. Nat Genet (1999) 1.81
The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res Hum Retroviruses (1995) 1.77
The pathology of frozen shoulder. J Bone Joint Surg Br (2007) 1.77
Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest (1993) 1.75
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood (2001) 1.74
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A (1998) 1.72
Depression in first-episode schizophrenia. Am J Psychiatry (1993) 1.71
Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis (1994) 1.71
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency. Hum Pathol (1972) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Enterobacter sakazakii: an emerging pathogen in powdered infant formula. Clin Infect Dis (2006) 1.63
Evaluation of vaginal infections in adolescent women: can it be done without a speculum? Pediatrics (1998) 1.63
A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo. Proc Natl Acad Sci U S A (1999) 1.62
Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest (1986) 1.61
Spatial control of the gap gene knirps in the Drosophila embryo by posterior morphogen system. Science (1992) 1.59
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
How reliable are SIDS rates? Arch Dis Child (2005) 1.57
Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem (1995) 1.57
Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis (1996) 1.55
Effectiveness of oral killed typhoid vaccine. Bull World Health Organ (1971) 1.54
A library of organic landscapes on filamentous phage. Protein Eng (1996) 1.53
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro. J Virol (2005) 1.53
Immune response to blood transfusion invery-low-birthweight infants. Transfusion (2000) 1.51
In vitro translation of the Two RNAs of Nodamura virus, a novel mammalian virus with a divided genome. J Virol (1978) 1.49
Alpha 1 antitrypsinin the livers of patients with emphysema. Science (1972) 1.49
Effects of asthma on cell components in peripheral blood among smokers and non-smokers. Clin Exp Allergy (2003) 1.48
Cyanopeptolins, new depsipeptides from the cyanobacterium Microcystis sp. PCC 7806. J Antibiot (Tokyo) (1993) 1.45
Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia (2000) 1.45
Alpha(1)-antitrypsin deficiency. Calif Med (1973) 1.45
Routine day-case laparoscopic cholecystectomy. Br J Surg (2004) 1.45
Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J Exp Med (1990) 1.44
Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity (1999) 1.42
Atomic-scale visualization of inertial dynamics. Science (2005) 1.42
Frequency of indeterminate western blot tests in healthy adults at low risk for human immunodeficiency virus infection. The NIAID AIDS Vaccine Clinical Trails Network. J Infect Dis (1990) 1.42
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
[To resuscitate or not? The emergency physician's decision in the prehospital setting]. Anasthesiol Intensivmed Notfallmed Schmerzther (2003) 1.40
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol (2000) 1.38
Upper and lower limb standards in newborn. Indian Pediatr (1989) 1.38